Prefilled half-life calculator
Zepbound half-life calculator
Zepbound contains Tirzepatide. The source-backed reference for Tirzepatide is ~120h (5 days); the prefilled calculator opens with that compound context.
A five-half-life model window for Zepbound is about 3.6 weeks. That is a calculation from the source value, not a measured individual result.
~120h (5 days)
This is a population-level source statement, not a measured concentration or individualized prediction.
5 days
The calculator link carries the compound label and 5 days half-life value into the tool.
Calculator setup
| Field | Prefilled value | Why it matters |
|---|---|---|
| Compound | Tirzepatide | Matches the public Halflife compound record. |
| Half-life | 5 days | Used only for first-order model arithmetic. |
| Five half-lives | 3.6 weeks | A common model reference window, not a clinical rule. |
| Evidence tier | fda | Shows whether the source is FDA, clinical, or lower-confidence evidence. |
Answer block to keep with the model
Zepbound should be interpreted through the exact source statement, route, formulation, and evidence tier. A half-life calculator can show mathematical decay and accumulation patterns, but it cannot measure a person, verify a product, or recommend a dose.
Source and limits
Primary source context: FDA NDA 215866. Full record: Tirzepatide half-life profile. Dataset anchor: public dataset record.
FAQs
What half-life does the Zepbound calculator use?
It uses the dataset statement for Tirzepatide: ~120h (5 days).
Is the Zepbound curve a measured blood concentration?
No. It is a one-compartment estimate based on the entered half-life and schedule assumptions.
Can this page decide dosing for Zepbound?
No. It is an educational calculator entry point and cannot determine a dose, route, timing, or clinical decision.
Track protocols with source labels intact
Halflife - Peptide & GLP-1 Log keeps injection records, model assumptions, vial context, and compound evidence labels visible in one iPhone app.
Download App